The new CRISPR platform, called ΨDNA, reprograms Cas12 nucleases to recognize and act on RNA using a DNA-based guide scaffold ...
A team of engineers at the University of Florida has developed a new form of CRISPR technology that could make diagnostics ...
Affecting an estimated 100,000 people globally, cystic fibrosis (CF) cases stem from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein. In the past several decades, ...
Sweet maize is often referred to as the 'King of fruits and vegetables' due to its richness in polysaccharides, dietary fiber, trace elements, vitamins, linoleic acid, and other essential nutrients.
CRISPR Cas9 genome editing has transformed the way scientists approach gene therapy, acting like precise DNA scissors that can target and repair hereditary diseases at the genetic level. This ...
In patients with sickle cell disease treated with ristoglogene autogetemcel, mean anti-sickling fetal hemoglobin levels were above 60% with a mean durable reduction in corresponding sickle hemoglobin ...
Hyper3D, developed by Deemos Tech, today announced the launch of Rodin Gen-2 Edit, also known as 3D Nano Banana, establishing itself as the first 3D generative AI editing platform. The new feature ...
The Pentagon used missiles untested in combat in a deadly attack that struck civilian sites near a military compound on Feb. 28, according to visual evidence examined by The Times and weapons experts.
CRISPR functions as a programmable genetic memory system derived from bacterial immune defenses against viral infections. Guide RNA allows for rapid multiplexed targeting compared to older ...
CRISPR Therapeutics' gene-editing platform looks fairly promising, but plenty of challenges could sink the stock. Vertex Pharmaceuticals has a robust underlying business along with some exposure to ...
One year ago, a baby from Delaware County, Pennsylvania, became the first person in the world to receive a new revolutionary therapy at Children's Hospital of Philadelphia. "We didn't know that we ...
Researchers have found that a new base-editing gene therapy can help treat a rare neurodevelopmental disorder called Snijders Blok–Campeau syndrome caused by mutations in the CHD3 gene. A specialized ...